Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Retained Earnings (2020 - 2026)

Journey Medical filings provide 6 years of Retained Earnings readings, the most recent being -$98.5 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 13.14% to -$98.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$98.5 million, a 13.14% decrease, with the full-year FY2025 number at -$98.5 million, down 13.14% from a year prior.
  • Retained Earnings hit -$98.5 million in Q4 2025 for Journey Medical, down from -$97.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$17.1 million in Q3 2021 to a low of -$98.5 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$80.7 million (2023), compared with a mean of -$72.5 million.
  • Biggest five-year swings in Retained Earnings: plummeted 859.26% in 2021 and later grew 0.97% in 2024.
  • Journey Medical's Retained Earnings stood at -$38.9 million in 2021, then crashed by 76.22% to -$68.5 million in 2022, then fell by 5.62% to -$72.4 million in 2023, then dropped by 20.28% to -$87.0 million in 2024, then fell by 13.14% to -$98.5 million in 2025.
  • The last three reported values for Retained Earnings were -$98.5 million (Q4 2025), -$97.2 million (Q3 2025), and -$94.9 million (Q2 2025) per Business Quant data.